We study vaccines with decades of experience and internationally recognized, high-quality scientific expertise. Our comprehensive network of ten clinics offers first-class prerequisites for this. We offer clinical expertise in phases 1-4 of vaccine research as well as investigations into the effectiveness and safety of vaccines already in use. We have strong expertise in Real-World Evidence (RWE) studies and pragmatic vaccine trials, utilizing Finland’s comprehensive health registers and data resources.
Study partner Net Promoter Score (NPS)*
Keeping agreed schedules in vaccine studies*
Reaching targets in vaccine studies*
Study volunteer satisfaction**
94% (positive feedback)
(*Vaccine manufacturer and monitor satisfaction study 2023; **HappyOrNot feedback devices at clinics)
Why work with FVR – Finnish Vaccine Research?
High degree of subject matter expertise in phases 1-4 of vaccine research, including registry / RWE data and large-scale pragmatic studies.
National network of ten clinics with just one clinical trial agreement.
Core focus on clinical vaccine research: it is our one and only priority.
Approx. 100 GCP-qualified research experts across Finland, with decades of accumulated experience.
Efficient enrollment of subjects, low drop-out rate.
Quick start-up processes and efficient administration: we are flexible, responsive and willing to improve and develop together.
No. of new launched studies each year, working with major vaccine manufacturers/big pharma R&D
Total no. of ongoing studies/ year
27 (in 2022)
Average no. of new enrolled volunteers /year (top year)
2,000-3,000 (top year for clinical trials 11,000, for pragmatic trials >30,000)
Study volunteer retention
approx. 2% drop-out rate from studies
Why conduct vaccine studies in Finland?
Educated and health-conscious people willing to participate in studies.
Exact enumeration of the population with potential to reach everyone.
High level of collaboration between public healthcare providers, enabling also large-scale pragmatic studies.
Extensive, high quality national health registers.
The reach of our clinics is not limited to their location as we also reach neighboring municipalities
Population size, end-2022
Helsinki (2 clinics)
(source: Statistics Finland)
Age % of tot. 5.6 million population
(source: statistics Finland)
Mika Rämet, M.D., Ph.D., Professor of Paediatrics and Experimental Immunology Chief Medical Officer at FVR mika.ramet (at) fvr.fi +358 50 433 6276
Arto Palmu, M.D., Ph.D., University lecturer in clinical epidemiology Chief Research Officer at FVR arto.palmu (at) fvr.fi +358 50 549 7113